Leaving No Stone Unturned

Leaving No Stone Unturned

Maybe this has happened to you. You’re diagnosed with a condition you’ve never heard of and prescribed a medication you can’t even pronounce. It’s highly treatable, but the pharmacist presents you with a bill for several hundred dollars, possibly a lot more.

The pharmacy team at Rx Savings Solutions searches all corners for savings opportunities, even for what may seem like obscure medications. Because the less common conditions are often the easiest targets for drug price-gouging!

Case in point: If you’ve ever suffered from an intestinal infection caused by Clostridium difficile (commonly known as “C. diff”), you and/or your health plan paid between $700 and $2,000 to treat it with oral Vancomycin capsules, an antibiotic typically used intravenously in hospitals for serious drug-resistant infections.

However, the same medication in oral liquid form has been commercially available for years in a solution compounding kit at less than $100. But, because compounding kits aren’t typically approved through the traditional FDA process, most plan formularies have neglected to cover it. That’s assuming they or a prescriber were even aware of it.

Our solution is and has been aware. It’s just another example of the clinical depth of our suggestion engine.

Fortunately, the FDA has finally approved a Vancomycin compounding kit, and CutisPharma is targeting April 2 as a launch date for FIRVANQ™. Prices remain to be seen.

Until then, count on Rx Savings Solutions to find the lowest-cost therapy options for this and every other condition. Sure, sometimes it’s like searching for the needle in the haystack. But we do whatever it takes to move the savings needle for our members and clients.

Vancomycin_table.jpg?mtime=20180209185348#asset:684